Bavarian Nordic smallpox vaccine scores two late-stage trial wins

An article from FierceVaccines
May 14, 2015

Though it's been eradicated, the threat of a smallpox outbreak is taken very seriously by public health officials, an ongoing concern that's helped Bavarian Nordic pay its bills through the years.

With an announcement Wednesday trumpeting two successful late-stage tests, the company has reason to believe it can advance its business with smallpox vaccine Imvamune.

Read the rest of the article here.

Common Disease Taxonomy: 
Common Vaccine Taxonomy: 
Common Management Taxonomy: 
0